Pharmaceutical regulatory data, drug approvals & compliance tracking
Home › Clinical Trials › Recruiting
This page provides comprehensive data and analytics for actively recruiting trials. Our database is updated regularly to ensure accuracy and relevance. Our methodology combines automated data collection with expert curation to ensure high-quality, reliable information. Each data point is verified against multiple sources before publication.
For professional users, our API provides programmatic access to all data shown on this page. Rate limits apply based on your subscription tier. Contact us for enterprise pricing. Industry experts recommend monitoring these metrics on a monthly basis to stay ahead of market shifts. Our data shows significant movement in several key indicators over the past quarter.
This page is part of the FDA News data platform, which offers comprehensive coverage across related categories. Navigate using the links above to explore other sections.
| Trial ID | Drug | Phase | Condition | Sites |
|---|---|---|---|---|
| NCT-2026-101 | ImmunoX | Phase 3 | Melanoma | 85 |
| NCT-2026-102 | CardioZ | Phase 2 | CHF | 42 |
| NCT-2026-103 | NeuroQ | Phase 2 | Alzheimer's | 120 |
| NCT-2026-104 | OncoPrime | Phase 3 | NSCLC | 95 |
| NCT-2026-105 | RheumaCare | Phase 2 | RA | 55 |
Data updated continuously. Last refresh: May 11, 2026 14:30 UTC.
